Catalysis of the Kemp elimination by antibodies elicited against a cationic hapten

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 19, 1997, Pages 2497-2502

  Genre Grandpierre, Arnaud ^a   Tellier, Charles ^a   Loirat, Marie Jeanne ^b   Blanchard, Dominique ^b   Hodgson, David R W ^c   Hollfelder, Florian ^c   Kirby, Anthony J ^c  

^a UNIVERSITÉ DE NANTES   (France)

^b CRTS   (France)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYTIC ANTIBODY; HAPTEN; ISOXAZOLE DERIVATIVE;

ANTIBODY COMBINING SITE; ARTICLE; CATALYSIS; DECOMPOSITION; KINETICS; MICHAELIS MENTEN KINETICS; REACTION ANALYSIS;

EID: 0030798274     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)10003-8     Document Type: Article

References (27)

1. (a) Schultz, P.G.; Lerner, R.A. Science 1995, 269, 1835-1842;
2. (b) Jacobsen, J.R.; Schultz, P.G. Curr. Opin. Struct. Biol. 1995, 5, 818-824.
3. (c) Stewart, J. D. and Benkovic, S. J. Nature (London), 1995, 375, 388-391.
4. Shokat, K.M.; Leumann C.J.; Sugasawara, R.; Schultz, P.G. Nature 1989, 338, 269-271.
5. Raymond, J.-L.; Janda, K.D.; Lerner, R.A. Angew. Chem. Int. Ed. Engl. 1991, 30, 1711-1713.
6. Thorn, S.N.; Daniels, R.G.; Auditor, M.-T.; Hilvert, D. Nature, 1995, 573, 228-230.
7. (a) Casey, M.L.; Kemp, D.S.; Paul, K.G.; Cox, D.D. J. Org. Chem., 1973, 38, 2294-2301;
8. (b) Kemp, D.S.; Casey, M.L. J. Am. Chem. Soc. 1973, 95, 6670-6680;
9. (c) Kemp, D.S.; Cox, D.D.; Paul, K.G. J. Am. Chem. Soc. 1975, 97, 7312-7318.
10. (a) Hollfelder, F.; Kirby, F.; Tawfik, D.S. Nature 1996, 383, 60-63;
11. (b) Kikuchi, K.; Thorn, S.N.; Hilvert, D. J. Am. Chem. Soc. 1996, 118, 8184-8185.
12. Kirby, A. J. Adv. Phys. Org. Chem. 1980, 17, 183-278.
13. (a) Kirby, A.J.; Percy, J.M. J.C.S., Perkin Trans. 2, 1989, 907;
14. (b) Kirby, A. J.; Parkinson, A. J. Chem. Soc., Chem. Commun., 1994, 707.
15. Blériot, Y.; Genre-Grandpierre, A.; Imberty, A.; Tellier, C. J. Carbohydr. Chem, 1996, 15, 985-1000.
16. Yu, J.; Hsieh, L.C.; Kochersperger, L.; Yonkovich, S.; Stephans, J.C.; Gallop, M.C.; Schultz, P.G. Angew. Chem. Int. Ed. Engl. 1994, 33, 339-341.
17. 2O myeloma cells. Antibodies were produced by growing ascites from their cell lines and purified by ammonium sulfate precipitation and protein A chromatography. Köhler, G.; Milstein, C. Nature 1975, 256, 495-497.
18. d were determined by competitive ELISA on plates coated with the complex hapten-BSA . (a) Stevens, F.J. Molec. Immun. 1987, 24, 1055-1060;
19. (b) Seligman, S.J. J. Immun. Meth. 1994, 168, 101-110.
20. Rates were determined by monitoring the release of 2 at 405nm in a microtiterplate reader. Catalytic clones were checked by their reduced activity in presence of hapten 3b (0.1 mM).
21. Kikuchi, K., Thorn, S. N.and Hilvert, D., J. Am. Chem. Soc., 1996, 118, 8184-5.
22. 1M glycine ethyl ester, 20 mM 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, pH 5.5, 2 h. Lundblad, R.L. Chemical reagents for protein modification, 2nd ed., CRC Press, Boca Raton, 1991, p 267.
23. Value corrected for the difference in basicity between 4B2 and 34E4 active site carboxylate using Brønsted equation (β = 0.73).
24. Hollfelder, F.; Tawfik, D., unpublished results.
25. (a) Koch, A.; Reymond, J.-L.; Lerner, R.A. J. Am. Chem. Soc., 1994, 116, 803-804;
26. (b) Reymond, J. L.; Reber, J. L.; Lerner, R. A. Angew. Chem., Intl. Ed. Engl., 1994, 33, 475-477;
27. (c) Suckling, C. J.; Tedford, M. C.; Bence, L. M.; Irvine, J. I.; Stimson, W. H. JCS, Perkin Trans. 1, 1993, 1925-1929.